ALX ONCOLOGY HOLDINGS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Alx Oncology Holdings Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q4 2024.
  • Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $5.86M, a 12.8% decline year-over-year.
  • Alx Oncology Holdings Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $27.1M, a 3.12% increase year-over-year.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2024 was $27.1M, a 3.12% increase from 2023.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2023 was $26.3M, a 10.2% increase from 2022.
  • Alx Oncology Holdings Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.8M, a 71.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $27.1M $5.86M -$863K -12.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 $28M $6.95M -$12K -0.17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $28M $7.25M +$1.02M +16.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $27M $7.03M +$680K +10.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $26.3M $6.72M +$426K +6.77% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 $25.8M $6.96M +$757K +12.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $25.1M $6.24M +$401K +6.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $24.7M $6.35M +$850K +15.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $23.8M $6.3M +$609K +10.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-06
Q3 2022 $23.2M $6.21M +$2.02M +48.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $21.2M $5.84M +$3.6M +161% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $17.6M $5.5M +$3.7M +206% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $13.9M $5.69M +$3.94M +226% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 $9.97M $4.19M +$3.5M +508% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.47M $2.24M -$616K -21.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $7.09M $1.8M +$1.65M +1092% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $5.44M $1.74M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 $689K +$603K +701% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.85M +$2.79M +4655% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $151K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 $86K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $60K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.